Menu Search
Equities

Theraclion SA

ALTHE:PAR

Theraclion SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)0.351
  • Today's Change0.000 / 0.00%
  • Shares traded1.00
  • 1 Year change-30.08%
  • Beta0.1605
Data delayed at least 15 minutes, as of Nov 14 2024 08:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Theraclion SA grew revenues 47.49% from 1.24m to 1.82m while net income improved from a loss of 4.96m to a smaller loss of 3.68m.
Gross margin102.48%
Net profit margin-277.68%
Operating margin-220.20%
Return on assets-19.94%
Return on equity-72.43%
Return on investment-26.41%
More ▼

Cash flow in EURView more

In 2023, Theraclion SA increased its cash reserves by 210.14%, or 5.30m. Cash Flow from Financing totalled 7.99m or 438.67% of revenues. In addition the company used 2.48m for operations while cash used for investing totalled 213.52k.
Cash flow per share-0.072
Price/Cash flow per share--
Book value per share0.0719
Tangible book value per share0.0461
More ▼

Balance sheet in EURView more

Theraclion SA has a Debt to Total Capital ratio of 33.03%, a lower figure than the previous year's 34.15%.
Current ratio3.62
Quick ratio2.69
Total debt/total equity0.4933
Total debt/total capital0.3303
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.